Authors: Rusnak, DW Affleck, K Cockerill, SG Stubberfield, C Harris, R Page, M Smith, KJ Guntrip, SB Carter, MC Shaw, RJ Jowett, A Stables, J Topley, P Wood, ER Brignola, PS Kadwell, SH Reep, BR Mullin, RJ Alligood, KJ Keith, BR Crosby, RM Murray, DM Knight, WB Gilmer, TM Lackey, K

Citation: Dw. Rusnak et al., The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer, CANCER RES, 61(19), 2001, pp. 7196-7203

Authors: Stuart, JD Lee, FW Noel, DS Kadwell, SH Overton, LK Hoffman, CR Kost, TA Tippin, TK Yeager, RL Batchelor, KW Bramson, HN

Citation: Jd. Stuart et al., Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5 alpha-reductases: determinants for different in vivo activitiesof GI198745 and finasteride in the rat, BIOCH PHARM, 62(7), 2001, pp. 933-942

Authors: Shewchuk, LM Hassell, AM Ellis, B Holmes, WD Davis, R Horne, EL Kadwell, SH McKee, DD Moore, JT

Citation: Lm. Shewchuk et al., Structure of the Tie2 RTK domain: Self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail, STRUCTURE, 8(11), 2000, pp. 1105-1113

Authors: Su, JL McKee, DD Ellis, B Kadwell, SH Wisely, GB Moore, LB Triantafillou, JA Kost, TA Fuqua, S Moore, JT

Citation: Jl. Su et al., Production and characterization of an estrogen receptor beta subtype-specific mouse monoclonal antibody, HYBRIDOMA, 19(6), 2000, pp. 481-487